Fundraising FoxAPRINOIA Therapeutics
1 known investors
Find your way into APRINOIA Therapeutics
Sign up to see every warm intro you have to APRINOIA Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the APRINOIA Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
APRINOIA is a clinical-stage biotech company developing diagnostic tools and therapies for neurodegenerative diseases. It focuses on precision medicine in neuroscience to improve diagnosis and treatment of brain disorders for patients.
Investors · 1
Frequently asked questions
- What does APRINOIA Therapeutics do?
- APRINOIA is a clinical-stage biotech company developing diagnostic tools and therapies for neurodegenerative diseases. It focuses on precision medicine in neuroscience to improve diagnosis and treatment of brain disorders for patients.
- Who are APRINOIA Therapeutics's investors?
- APRINOIA Therapeutics's investors include IMM Investment Japan.